- Co-amilofruse 2.5mg/20mg tablets
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Co-amilofruse 2.5mg/20mg tablets | Start Date 04-05-2004 | End Date |
Previous Name | Previous Name Co-amilofruse 2.5/20 tablets | Start Date 11-10-2002 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- BAN - British Approved Name
Codes
- ATC Code
- C03EB01
BNF | Start Date | End Date |
---|---|---|
Current BNF 02020400 | Start Date 04-04-2022 | End Date |
Previous BNF 02020400 | Start Date 01-02-2005 | End Date 03-04-2022 |
Code | Start Date | End Date |
---|---|---|
42293311000001101 | 29-09-2023 | |
318135008 | 11-10-2002 | 28-09-2023 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Amiloride hydrochloride | Based on Ingredient Substance | 2.5 mg | ||
Furosemide | Based on Ingredient Substance | 20 mg |
Name
Amiloride hydrochloride
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
2.5
Strength and UOM (Dmr)
Name
Furosemide
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
20
Strength and UOM (Dmr)
Parent Products
-
VTMCo-amilofruse
-
VMP(Current) Co-amilofruse 2.5mg/20mg tablets
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
28 tablet | 493 | Part VIIIA Category A |
56 tablet |